Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aldesleukin (Proleukin) (1 trial)
allogeneic natural killer cells (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
busulfan (Myleran) (1 trial)
cd3,cd19 depleted hematopoietic stem cells (1 trial)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (1 trial)
melphalan (alkeran) (1 trial)
plerixafor (mozobil) (1 trial)
thiamine (1 trial)
thiotepa (1 trial)
Beriberi (Phase 2)
Delirium (Phase 2)
Thiamine Deficiency (Phase 2)
Trials (2 total)
Trial APIs (11 total)